Elena Wen-Yuan Hsieh

Elena Wen-Yuan Hsieh

Auto-generated profile, based on publicly available information

Elena Wen-Yuan Hsieh

Department of Pediatrics & Internal Medicine, Division of Allergy and Immunology, UT Southwestern Medical Center, Dallas, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 October 2019 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
RSRonald P. Schuyler
Ronald P. Schuyler
CJConner Jackson
Conner Jackson
JGJosselyn E. Garcia-Perez
Josselyn E. Garcia-Perez
RBRyan M. Baxter
Ryan M. Baxter
SOSidney Ogolla
Sidney Ogolla
EHElena W. Y. Hsieh
Elena W. Y. Hsieh
Cytometry by Time-Of-Flight (CyTOF) uses antibodies conjugated to isotopically pure metals to identify and quantify a large number of cellular features with single-cell resolution. A barcoding approach allows for 20 unique samples to be pooled and processed together in one tube, reducing the intra-barcode technical variability. However, with only 20 samples per barcode, multiple barcode sets (batches) are required to address questions in robustly powered study designs. A batch adjustment procedure is required to reduce variability across batches and to facilitate direct comparison of runs performed across multiple barcodes run over weeks, months, or years. We describe a method using technical replicates that are included in each run to determine and apply an appropriate adjustment per batch without manual intervention. The use of technical replicate samples (i.e., anchors or reference samples) avoids assumptions of sample homogeneity among batches, and allows direct estimation of batch effects and appropriate adjustment parameters applicable to all samples within a batch. Quantification of cell subpopulations and mean signal intensity pre- and post-adjustment using both manual gating and unsupervised clustering demonstrate substantial mitigation of batch effects in the anchor samples used for this adjustment calculation, and in a second validation set of technical replicates.

25 February 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MGMatthew D. Galbraith
Matthew D. Galbraith
KKKohl T. Kinning
Kohl T. Kinning
KSKelly D. Sullivan
Kelly D. Sullivan
PAPaula Araya
Paula Araya
KSKeith P. Smith
Keith P. Smith
JEJoaquin M. Espinosa
Joaquin M. Espinosa
Significance: The interferon (IFN) family of proteins plays key roles in the immune response against viruses and other pathogens. In the context of COVID-19, IFNs have been shown to be key for restraining SARS-CoV-2 infection but have also been described as drivers of severe symptoms. However, it is not fully understood how each member of the IFN family contributes to distinct aspects of COVID-19. We report here the results of a deep examination of 12 different IFNs in hospitalized COVID-19 patients, which revealed clear differences among IFNs in their associations with molecular, cellular, and physiological processes relevant to COVID-19 presentation.

30 April 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
IFIsabel Z. Fernandez
Isabel Z. Fernandez
RBRyan M. Baxter
Ryan M. Baxter
JGJosselyn E. Garcia-Perez
Josselyn E. Garcia-Perez
EVElena Vendrame
Elena Vendrame
TRThanmayi Ranganath
Thanmayi Ranganath
EHElena W.Y. Hsieh
Elena W.Y. Hsieh
The pleiotropic actions of interleukin-2 (IL-2) are essential for regulation of immune responses and maintenance of immune tolerance. The IL-2 receptor (IL-2R) is composed of IL-2Rα, IL-2Rβ, and IL-2Rγ subunits, with defects in IL-2Rα and IL-2Rγ and their downstream signaling effectors resulting in known primary immunodeficiency disorders. Here, we report the first human defect in IL-2Rβ, occurring in two infant siblings with a homozygous IL2RB mutation in the WSXWS motif, manifesting as multisystem autoimmunity and susceptibility to CMV infection. The hypomorphic mutation results in diminished IL-2Rβ surface expression and dysregulated IL-2/15 signaling, with an anticipated reduction in regulatory T cells. However, in contrast to the IL-2Rβ−/− animal model, which lacks NK cells, these siblings demonstrate an expansion of NK cells, particularly the CD56bright subset, and a lack of terminally differentiated NK cells. Thus, the early-onset autoimmunity and immunodeficiency are linked to functional deficits arising from altered IL-2Rβ expression and signaling in T and NK cells. Graphical Abstract

1 July 2017 in Journal of Autoimmunity
Verified
Journal Article
Open access
WOW.E. O'GOrman
W.E. O'GOrman
DKD.S. Kong
D.S. Kong
IBI.M. Balboni
I.M. Balboni
PRP. Rudra
P. Rudra
CBC.R. Bolen
C.R. Bolen
EHE.W.Y. Hsieh
E.W.Y. Hsieh
Systemic Lupus Erythematosus (SLE) is a heterogeneous autoimmune disease with heightened disease severity in children. The incomplete understanding of the precise cellular and molecular events that drive disease activity pose a significant hurdle to the development of targeted therapeutic agents. Here, we performed single-cell phenotypic and functional characterization of pediatric SLE patients and healthy controls blood via mass cytometry. We identified a distinct CD14hi monocyte cytokine signature, with increased levels of monocyte chemoattractant protein-1 (MCP1), macrophage inflammatory protein-1β (Mip1β), and interleukin-1 receptor antagonist (IL-1RA). This signature was shared by every clinically heterogeneous patient, and reproduced in healthy donors' blood upon ex-vivo exposure to plasma from clinically active patients only. This SLE-plasma induced signature was abrogated by JAK1/JAK2 selective inhibition. This study demonstrates the utility of mass cytometry to evaluate immune dysregulation in pediatric autoimmunity, by identification of a multi-parametric immune signature that can be further dissected to delineate the events that drive disease pathogenesis.

27 November 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
PDPatrick Danaher
Patrick Danaher
NHNicholas Hasle
Nicholas Hasle
ENElizabeth D. Nguyen
Elizabeth D. Nguyen
JRJordan E. Roberts
Jordan E. Roberts
NRNatalie Rosenwasser
Natalie Rosenwasser
SJShaun W. Jackson
Shaun W. Jackson
Children with systemic lupus erythematosus (SLE) are at increased risk of developing kidney disease, termed childhood-onset lupus nephritis (cLN). Single-cell transcriptomics of dissociated kidney tissue has advanced our understanding of LN pathogenesis, but loss of spatial resolution prevents interrogation of in situ cellular interactions. Using a technical advance in spatial transcriptomics, we generated a spatially resolved, single-cell resolution atlas of kidney tissue from eight patients with cLN and four control individuals. Annotated cells were assigned to 30 reference cell types, including major kidney subsets and infiltrating immune cells. Analysis of spatial distribution demonstrated that individual immune lineages localized to specific regions in cLN kidneys, including myeloid cells that trafficked to inflamed glomeruli and B cells that clustered within tubulointerstitial immune hotspots. Gene expression varied as a function of tissue location, demonstrating how incorporation of spatial data can provide new insights into the immunopathogenesis of SLE. Alterations in immune phenotypes were accompanied by parallel changes in gene expression by resident kidney stromal cells. However, there was little correlation between histologic scoring of cLN disease activity and glomerular cell transcriptional signatures at the level of individual glomeruli. Last, we identified modules of spatially correlated gene expression with predicted roles in induction of inflammation and the development of tubulointerstitial fibrosis. Single-cell spatial transcriptomics allowed insights into the molecular heterogeneity of cLN, paving the way toward more targeted and personalized treatment approaches.

13 May 2021 in Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
CCCathleen Collins
Cathleen Collins
ESEmily Sharpe
Emily Sharpe
ASAbigail Silber
Abigail Silber
SKSarah Kulke
Sarah Kulke
EHElena W. Y. Hsieh
Elena W. Y. Hsieh
Congenital athymia is an ultra-rare disease characterized by the absence of a functioning thymus. It is associated with several genetic and syndromic disorders including FOXN1 deficiency, 22q11.2 deletion, CHARGE Syndrome (Coloboma, Heart defects, Atresia of the nasal choanae, Retardation of growth and development, Genitourinary anomalies, and Ear anomalies), and Complete DiGeorge Syndrome. Congenital athymia can result from defects in genes that impact thymic organ development such asFOXN1andPAX1or from genes that are involved in development of the entire midline region, such asTBX1within the 22q11.2 region,CHD7, andFOXI3. Patients with congenital athymia have profound immunodeficiency, increased susceptibility to infections, and frequently, autologous graft-versus-host disease (GVHD). Athymic patients often present with absent T cells but normal numbers of B cells and Natural Killer cells (T−B+NK+), similar to a phenotype of severe combined immunodeficiency (SCID); these patients may require additional steps to confirm the diagnosis if no known genetic cause of athymia is identified. However, distinguishing athymia from SCID is crucial, as treatments differ for these conditions. Cultured thymus tissue is being investigated as a treatment for congenital athymia. Here, we review what is known about the epidemiology, underlying etiologies, clinical manifestations, and treatments for congenital athymia.